LNA Santé SA (EPA:LNA)
France · Delayed Price · Currency is EUR 34.70
0.00 (0.00%)
Aug 3, 2026, 3:00 PM CET
LNA Santé Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 25.72 | 22.92 | 24.23 | 28.33 | 23.99 |
Depreciation & Amortization | 91.65 | 91.81 | 85.37 | 85.36 | 81.61 |
Other Adjustments | 42.66 | 33.26 | 37.03 | 24.82 | 32.01 |
Change in Receivables | -8.5 | -14.4 | 12.14 | -0.66 | -16 |
Changes in Inventories | -42.12 | -33.99 | -52.05 | -19.76 | 1.41 |
Changes in Accounts Payable | 4.17 | 24.63 | 1.06 | 2.27 | -28.84 |
Changes in Income Taxes Payable | -14.16 | -13.79 | -10.27 | -17.17 | -14.25 |
Operating Cash Flow | 99.42 | 110.44 | 97.5 | 103.2 | 79.92 |
Operating Cash Flow Growth | -9.98% | 13.27% | -5.52% | 29.13% | -45.45% |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -11.13 | -10.82 | -11.53 | -11.96 | -10.24 |
Sale of Property, Plant & Equipment | 0.12 | 0.1 | 0.1 | 0.88 | 0.08 |
Purchases of Intangible Assets | -1.91 | -1.35 | -1.3 | -1.38 | -3.46 |
Proceeds from Sale of Intangible Assets | - | 1.83 | - | - | - |
Purchases of Investments | -0.47 | -0.51 | -0.29 | -0.26 | -0.81 |
Proceeds from Sale of Investments | 0.41 | 0.41 | 0.42 | 0.33 | 2.88 |
Cash Acquisitions | -1.55 | -13.76 | -3.18 | -29.78 | -15.85 |
Other Investing Activities | 0.33 | 0.39 | 0.09 | 0.2 | -0.24 |
Investing Cash Flow | -14.18 | -23.72 | -15.69 | -41.99 | -27.65 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | 15.88 | 3.88 | 4.04 | 4.09 | 3.56 |
Net Short-Term Debt Issued (Repaid) | 15.88 | 3.88 | 4.04 | 4.09 | 3.56 |
Long-Term Debt Issued | 58.28 | 50.75 | 55.51 | 148.42 | 140.5 |
Long-Term Debt Repaid | -102.84 | -107.87 | -127.06 | -282.77 | -298.26 |
Net Long-Term Debt Issued (Repaid) | -44.56 | -57.12 | -71.56 | -134.36 | -157.76 |
Issuance of Common Stock | - | - | - | 49.94 | 1.75 |
Repurchase of Common Stock | - | - | -6.52 | -4.44 | -0.52 |
Net Common Stock Issued (Repurchased) | - | - | -6.52 | 45.5 | 1.23 |
Common Dividends Paid | -6.67 | -6.14 | -6 | -4.52 | -1.92 |
Other Financing Activities | -30.17 | -29.43 | -26.65 | -21.6 | -19.53 |
Financing Cash Flow | -65.52 | -88.8 | -106.69 | -110.88 | -21.53 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 19.71 | -2.08 | -24.87 | -49.66 | 30.75 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 88.29 | 99.62 | 85.98 | 91.24 | 69.68 |
Free Cash Flow Growth | -11.37% | 15.87% | -5.77% | 30.94% | -49.30% |
FCF Margin | 9.67% | 12.35% | 11.68% | 12.53% | 10.11% |
Free Cash Flow Per Share | 8.61 | 9.74 | 8.41 | 8.81 | 7.26 |
Levered Free Cash Flow | 23.87 | 26.42 | -31.53 | -65.71 | -101.01 |
Unlevered Free Cash Flow | 72.88 | 100.08 | 53.58 | 79.01 | 63.04 |